DHR
DanaherDNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-17
Current thesis
Bioprocessing and Life Sciences recovery can persist, Diagnostics can stabilize, and the Masimo transaction can improve mix and EPS leverage if regulatory clearance and integration proceed cleanly. If those pieces hold, the stock can move closer to the Street's median target of 264.19 than the current 161.91 anchor price.
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-07-21 · BMO.
What can break
Diagnostics remains the weakest segment; Q1 core growth was only 0.5%, and Cepheid's lighter respiratory season highlighted how uneven the recovery still is.
Momentum
43
Value
62
Sentiment
28
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $168.00 · Bull $205.00 · Bear $132.00
Earnings
86 · High quality
Next 2026-07-21 · BMO
Data freshness
Prices
As of 2026-07-17
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-17 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-18 • Model: RankAlpha Sentiment Codex
Earnings Setup
As of 2026-07-17 • RankAlpha AI
Investment thesisAs of 2026-07-17
Investment thesis
As of 2026-07-17
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $241.27
Why
Momentum43 · Δ7d -16.1
Value62 · Δ7d -0.3
Sentiment28 · Δ7d -7.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Earnings surprise screen
86High quality2026-07-21 bmo
Danaher combines a positive +0.62% Earnings ESP, consensus Q2 revenue of approximately $6.09 billion, management commentary on a recovery led by bioprocessing and Life Sciences, strong pre-event price action, a 0.95 close-location reading, and relative strength versus XLV; the main caution is disclosed shareholder litigation and only modest revenue growth.
Screen as of 2026-07-17. Window 2026-07-17 to 2026-07-23.
Lead driver: Value · See fundamentals
Momentum
43
26% active weight
Current posture
7d trendImproving
Δ7d
-16.1
Δ21d
-4.7
Value
62
39% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-0.2
Sentiment
28
34% active weight
Current posture
7d trendSoftening
Δ7d
-7.9
Δ21d
-5.9
Why this grade
Composite grade D. Momentum 42.7 / Value 62.0 / Sentiment 28.4
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$144.26B
Beta
0.92
Shares Out
707.77M
P/E (TTM)
48.4
P/S (TTM)
6.85
P/FCF (TTM)
39.87
Rev YoY
+3.7%
EPS YoY
+9.3%
Gross Margin
+61.1%
Op Margin
+19.0%
Net Debt
$15.08B
Current Ratio
1.87
As of 2026-07-17 • Updated nightlySource: Internal modelMethodology